Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Current Deferred Tax Assets (2009 - 2015)

Johnson & Johnson's (JNJ) quarterly Current Deferred Tax Assets came in at $3.6 billion in Q3 2015, down 5.77% year-over-year from $3.8 billion in Q3 2014, and down 3.14% quarter-over-quarter from $3.7 billion in Q2 2015.

Analysis

Johnson & Johnson (JNJ) Current Deferred Tax Assets (2009 - 2015) Analysis & Trends

Johnson & Johnson has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $3.6 billion for Q3 2015.

  • In Q3 2015, Current Deferred Tax Assets fell 5.77% year-over-year to $3.6 billion; the TTM figure through Sep 2015 stood at $3.6 billion (down 5.77% YoY), while the FY2014 annual figure was $3.6 billion, down 1.11% from the prior year.
  • Current Deferred Tax Assets came in at $3.6 billion for Q3 2015 at Johnson & Johnson, down from $3.7 billion in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $4.1 billion in Q2 2014 to a low of $2.2 billion in Q1 2011.
  • Average Current Deferred Tax Assets over 5 years is $3.2 billion, with a median of $3.3 billion recorded in 2012.
  • Year-over-year, Current Deferred Tax Assets fell 20.37% in 2011 and jumped 35.17% in 2012.
  • Over 5 years, Current Deferred Tax Assets stood at $2.5 billion in 2011, then advanced by 26.57% to $3.1 billion in 2012, then climbed by 14.91% to $3.6 billion in 2013, then decreased by 1.11% to $3.6 billion in 2014, then climbed by 1.09% to $3.6 billion in 2015.
  • Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $3.6 billion in Q3 2015, $3.7 billion in Q2 2015, and $3.5 billion in Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2015 3.61 Bn
Jun 28, 2015 3.72 Bn
Mar 29, 2015 3.52 Bn
Dec 28, 2014 3.57 Bn
Sep 28, 2014 3.83 Bn
Jun 29, 2014 4.10 Bn
Mar 30, 2014 3.92 Bn
Dec 29, 2013 3.61 Bn
Sep 29, 2013 3.49 Bn
Jun 30, 2013 3.28 Bn
Mar 31, 2013 3.09 Bn
Dec 30, 2012 3.14 Bn
Sep 30, 2012 3.25 Bn
Jul 1, 2012 3.12 Bn
Apr 1, 2012 2.70 Bn
Jan 1, 2012 2.56 Bn
Oct 2, 2011 2.48 Bn
Jul 3, 2011 2.31 Bn
Apr 3, 2011 2.27 Bn
Jan 2, 2011 2.22 Bn